COLL
COLL clinical trials: COLLEGIUM PHARMACEUTICAL, INC
Every trial on ClinicalTrials.gov where COLLEGIUM PHARMACEUTICAL, INC is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 4
- Trials linked
- 1
- As lead sponsor
- 3
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
COLL on the catalyst calendar · COLL registry changes
- Primary completion Jun 2014ActualPhase 3NCT01685684Oxycodone DETERx™ Versus Placebo in Chronic Low Back Pain (CLBP)Collegium Pharmaceutical, Inc. · Chronic Low Back PainCompletedCOLLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2029Sponsor estimatePhase 4NCT07838311Delayed-Release, Extended-Release Methylphenidate (Jornay PM) for Adolescents and Young Adults With Attention-Deficit/Hyperactivity...Massachusetts General Hospital · ADHDNot yet recruitingCOLLCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 11, 2025ActualPhase 3NCT06431256Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years With ADHDIronshore Pharmaceuticals and Development, Inc · Attention Deficit Hyperactivity DisorderTerminatedCOLLCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 31, 2019ActualPhase 4NCT03588806Use of Xtampza ER to Overcome Difficulties in Swallowing Opioid PillsAjay Wasan, MD, Msc · Chronic PainTerminatedCOLLCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner